Table 3.
Surveillance drug resistance mutations detected and HIV-1 subtypes for patients with viral loads 1000 copies/mL (N = 33).
| Patient ID | Viral load (copies/mL) | Major HIV drug resistance-associated mutations | HIV-1 Sub-type | |||
|---|---|---|---|---|---|---|
| NRTI | NNRTI | PI | INSTI | |||
| CR-014 | 150,000 | ND | ND | ND | ND | A |
| CR-048 | 2980 | D67N, K70R, M184V, T215F, K219E | K103N | ND | G118R, E138K | A |
| CR-063 | 6290 | M184V | ND | ND | ND | D |
| CR-119 | 292,000 | M184V | ND | ND | ND | A,D |
| CR-177 | 1320 | ND | ND | ND | ND | C |
| CR-226 | 1210 | ND | K103N | ND | ND | C |
| CR-335 | 3650 | ND | K101E | ND | ND | C |
| CR-339 | 1910 | GF | GF | GF | ND | C |
| CR-356 | 11,100 | ND | ND | ND | ND | A |
| FD-047 | 36,700 | GF | GF | ND | ND | A |
| FD-089 | 2840 | GF | GF | GF | GF | GF |
| FD-096 | 1430 | D67N, K70R, M184V, K219E | Y181C, G190A | ND | GF | A |
| FD-143 | 103,000 | GF | GF | ND | ND | C |
| GD-103 | 326,000 | ND | K103N | ND | ND | C |
| GD-107 | 7540 | ND | ND | ND | ND | A |
| MC-059 | 12,300 | M41L, M184V, T215F | K101E, G190A | ND | ND | A |
| MC-111 | 1370 | GF | GF | GF | ND | A |
| MC-118 | 1500 | GF | GF | GF | GF | GF |
| MC-122 | 327,000 | ND | K103N | ND | ND | A,D |
| MC-125 | 284,000 | ND | ND | ND | ND | A |
| MC-210 | 125,000 | GF | GF | ND | ND | A |
| MC-222 | 2240 | M184V | ND | ND | ND | A,D |
| MC-243 | 4000 | K65R, M184V, K219Q | K103S, G190A | ND | E138K, G140A, Q148K | A |
| MC-339 | 375,000 | GF | GF | ND | ND | C |
| MC-347 | 58,700 | ND | ND | ND | ND | D |
| MC-354 | 1390 | GF | GF | ND | ND | A |
| MC-367 | 13,900 | M41L, M184V, L210W, T215Y | G190A | ND | T66I, G118R, E138K | C |
| MC-400 | 30,100 | ND | ND | ND | ND | C |
| MU-050 | 1900 | ND | ND | ND | ND | C |
| MZ-030 | 128,000 | ND | ND | ND | ND | A |
| MZ-113 | 3590 | GF | GF | ND | ND | D |
| MZ-207 | 2130 | ND | K103NS | ND | ND | A |
| MZ-262 | 2830 | ND | ND | ND | ND | C |
NRTI nucleoside reverse transcriptase inhibitors, NNRTI non-nucleoside reverse transcriptase inhibitors, PI protein inhibitor, INSTI integrase strand transfer inhibitor, ND none detected, GF genotyping failure.